Air Canada has announced it has engaged Spartan Bioscience, an Ottawa-based biotechnology leader in portable DNA testing technology, to assess how best to deploy Spartan’s portable COVID-19 testing technology in the aviation sector. “Air Canada’s strategy for managing COVID-19 has been to develop and apply multiple layers of biosafety measures for customers and employees. We believe the availability of a rapid, accurate, portable molecular test for COVID-19 will add yet another effective layer. We are excited by the potential and point of care use cases for the Spartan Cube, and look forward to working with the Spartan team in the weeks

This content is restricted to site members.

If you are an existing user, please login below.
New users may register below.

Existing Users Log In